Veracyte, formerly HalioDx, is a global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions throughout the patient journey in cancer and other diseases.
Our immuno-oncology diagnostic products and services are used to guide cancer care and contribute to precision medicine in the era of immuno-oncology and combination therapies.
The company provides a unique range of immune scoring solutions, including the Immunoscore® assay for assessing the immune contexture of a tumor.
Immunoscore® in colon cancer is available as a CLIA or CE marked test to guide day-to-day oncologists’ decisions. Immunoscore® can be a diagnostic platform for many cancers, as immune response to tumor is a key hallmark of disease progression